Form 4: Guardant Health Director Mignone Acquires Shares

Guardant Health Director Roberto Mignone reported the acquisition of 264 shares of common stock through the vesting of restricted stock units.

Summary

• Roberto Mignone, a Director at Guardant Health, Inc. (GH), acquired 264 shares of common stock.
• The acquisition occurred on March 21, 2026, through the vesting of Restricted Stock Units (RSUs).
• The transaction price for the acquired shares was $0, typical for RSU vesting.
• Following this transaction, Mignone directly beneficially owns 4,487 shares of common stock.
• Mignone also directly beneficially owns 8,184 derivative securities in the form of Restricted Stock Units.
• The Restricted Stock Unit award was originally granted on November 8, 2024, with a four-year vesting period.
• 25% of the RSU award vested on the one-year anniversary of October 21, 2024, with the remaining 75% vesting monthly over the subsequent three-year period.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event. While not a discretionary purchase, the vesting and retention of shares by a director increases their direct ownership, signaling continued alignment with the company's long-term performance.

Positives

• Increased direct beneficial ownership by a Director, Roberto Mignone, through the vesting of 264 shares of common stock, aligning his interests further with shareholders.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's financial performance or strategic direction, focusing solely on an insider transaction.

Industry Context

StockSavvy.ai notes that routine insider acquisitions, such as those from RSU vesting, are common and generally viewed as a neutral to slightly positive signal, indicating continued commitment from management and board members. While not a discretionary purchase, it maintains or increases insider alignment with shareholder value.

Stakeholder Impact

• Shareholders may view the increased direct ownership by a director as a positive sign of continued commitment to the company's success.

Next Steps

• Remaining 75% of the RSU award will continue to vest monthly over the three-year period following the one-year anniversary of October 21, 2024.

Key Dates

Keywords

Guardant Health, GH, Form 4, Insider Transaction, Roberto Mignone, Director, Common Stock, Restricted Stock Units, RSU Vesting